Hepatic Myeloid Sarcoma Presenting With Recurrent Ascites: A Case Report
Cureus · 26.03.2026
DOI: 10.7759/cureus.105880 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 26.03.2026. Verfasst von Mossaab El Mousadik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Hematology and Cellular Therapy, Mohammed VI University Hospital Center, Ibn Zohr University, Agadir, MAR. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Hematology and Cellular Therapy, Mohammed VI University Hospital Center, Ibn Zohr University, Agadir, MAR.
- Hematology, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
- Oncopathology, Cancer Biology, and Environment Laboratory, Mohammed VI Faculty of Medicine, Center for Doctoral Studies (CEDoc), Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
- Hematology, Faculty of Medicine, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
- Pathology, Ibn Sina University Hospital Center, Rabat, MAR.
- Hematology, Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
Zitieren
APA
El Mousadik, M., Fadi, M., Saad, Z., Lamalmi, N., & Bouanani, N. (2026). Hepatic Myeloid Sarcoma Presenting With Recurrent Ascites: A Case Report. Cureus. https://doi.org/10.7759/cureus.105880
Vancouver
El Mousadik M, Fadi M, Saad Z, Lamalmi N, Bouanani N. Hepatic Myeloid Sarcoma Presenting With Recurrent Ascites: A Case Report. Cureus. 2026. doi:10.7759/cureus.105880
BibTeX
@article{ElMousadik2026,
author = {El Mousadik, Mossaab and Fadi, Monsif and Saad, Zoubida and Lamalmi, Najat and Bouanani, Nouama},
title = {Hepatic Myeloid Sarcoma Presenting With Recurrent Ascites: A Case Report},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.105880}
}
EUVIMED